Not Yet Recruiting
Long Term Efficacy of Faricimab Using a Treat and Extend Regimen for Type 3 Macular Neovascularization
NCT07187804
- Conditions
- Age-Related Macular Degeneration (ARMD), Anti-vascular Endothelial Growth Factor, Choroid Diseases, +10 more
- Locations
-
- Kim's Eye Hospital Seoul, South Korea